Exegi Pharma Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Exegi Pharma

Access the complete profile.

Exegi Pharma Fast Facts

Revenue	$1 - $10 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Address	77 Upper Rock Circle #102 Rockville, MD 20850

Note: Revenues for privately held companies are statistical evaluations.


Exegi Pharma's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Exegi Pharma's annual revenues are $1 - $10 million (see exact revenue data)
• What industry is the company in?
  • Exegi Pharma is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Exegi Pharma Annual Revenue and Growth Rate

Exegi Pharma	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$1 - $10 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Exegi Pharma's revenues are gauged from an analysis of company filings.

Exegi Pharma's Income Statement (based on Industry Averages)

Exegi Pharma P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Exegi Pharma is developing and marketing. Exegi Pharma doesn't have any recent trademark applications, indicating Exegi Pharma is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
SIVOVET Food supplements; Food supplements for animals for treating and preventing digestive disorders; Health food supplements for animals; Nutritional supplements, namely, probiotic compositions for animals; Dietary and nutritional supplements for animals; Live biotherapeutics for animals for the treatment and prevention of inflammatory bowel diseases, ulcerative colitis, irritable bowel syndrome, pouchitis, liver diseases, viral diseases; Medical Food, namely, dietetic foods for animals in the nature of powder specially adapted for medical use; Probiotic supplements for animals	04/24/2020
SIVOBIOME Food supplements; Food supplements for treating digestive disorders; Health food supplements; Nutritional supplements, namely, probiotic compositions; Dietary and nutritional supplements; Pharmaceutical preparations for the treatment and prevention of inflammatory bowel diseases, ulcerative colitis, irritable bowel syndrome, pouchitis, liver diseases, viral diseases; Drugs, Biologic drugs and live biotherapeutics for the treatment and prevention of inflammatory bowel diseases, ulcerative colitis, irritable bowel syndrome, pouchitis, liver disease, viral diseases; Medical Food, namely, dietetic foods in the nature of powder specially adapted for medical use; Probiotic supplements	04/07/2020
FELIOME Food supplements; Food supplements for animals for treating digestive disorders; Health food supplements for animals; Nutritional supplements, namely, probiotic compositions for animals; Dietary and nutritional supplements for animals; Live biotherapeutics for animals for the treatment of inflammatory bowel diseases, ulcerative colitis, irritable bowel syndrome, pouchitis, liver diseases; Medical Food, namely, dietetic foods for animals in the nature of powder specially adapted for medical use; Probiotic supplements for animals	03/31/2020

See all trademarks and details in the Full Report.

Market Share of Exegi Pharma's Largest Competitors

A competitive analysis shows these companies are in the same general field as Exegi Pharma, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Exegi Pharma. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
EMERGENT BIOSOLUTIONS	Gaithersburg, MD	100
SUPERNUS PHARMACEUTICALS	Rockville, MD	62
AURINIA PHARMA US	Rockville, MD	28
VIGENE BIOSCIENCES	Rockville, MD	15
ORIGENE TECHNOLOGIES	Rockville, MD	13
NEUMODX	Germantown, MD	13

Other Companies at 77 Upper Rock Circle, Rockville MD

Company	Headquarters	Revenue ($ MM)
AURINIA PHARMA US	Rockville, MD	100
TETRACORE	Rockville, MD	13
SPARKS PERSONNEL SERVICES	Rockville, MD	6
POTOMAC-HUDSON ENGINEERING	Rockville, MD	2
DASCENA LABS	Rockville, MD	2

Future Competition: Exegi Pharma's Fastest Growing Competitors

These companies are in the same general field as Exegi Pharma and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)